KRT18 and COVID-19: Genetically modified mice that express hACE2, especially the K18‐hACE2 and CAG‐hACE2 transgenic mice which characterize the severe disease of COVID‐19 patients with ARDS or SIRS, and Syrian hamsters are widely used as rapid models.